Geertje Maria de Boer

9PUBLICATIONS
24CO-AUTHORS
AllergyInfectious agentsMajor global burdens of diseaseRespiratory diseasesInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 20, 2024
Aberrant characteristics of peripheral blood innate lymphoid cells in COPD, independent of smoking history.

Cathelijne M van Zelst, Johannes C C M In 't Veen, Lisette Krabbendam

|Aug 23, 2023
Type-2 CD8+ T-cell formation relies on interleukin-33 and is linked to asthma exacerbations.

Esmee K van der Ploeg, Lisette Krabbendam, Heleen Vroman

|Jul 21, 2021
Bacterial lysate add-on therapy to reduce exacerbations in severe asthma: A double-blind placebo-controlled trial.

Geertje M de Boer, Gert-Jan Braunstahl, Esmee K van der Ploeg

|Jul 05, 2021
Asthma patients experience increased symptoms of anxiety, depression and fear during the COVID-19 pandemic.

Geertje M de Boer, Laura Houweling, Rudi W Hendriks

|May 06, 2021
Asthma exacerbation prevalence during the COVID-19 lockdown in a moderate-severe asthma cohort.

Geertje de Boer, Gert-Jan Braunstahl, Rudi Hendriks

|Jan 30, 2021
Steroid-resistant human inflammatory ILC2s are marked by CD45RO and elevated in type 2 respiratory diseases.

Esmee K van der Ploeg, Korneliusz Golebski, Menno van Nimwegen

Pageof 2